AMPH
Price
$24.32
Change
+$1.02 (+4.38%)
Updated
May 15 closing price
Capitalization
2.11B
87 days until earnings call
ZTS
Price
$160.35
Change
+$5.43 (+3.51%)
Updated
May 15 closing price
Capitalization
77.48B
88 days until earnings call
Ad is loading...

AMPH vs ZTS

Header iconAMPH vs ZTS Comparison
Open Charts AMPH vs ZTSBanner chart's image
Amphastar Pharmaceuticals
Price$24.32
Change+$1.02 (+4.38%)
Volume$667.74K
Capitalization2.11B
ZOETIS
Price$160.35
Change+$5.43 (+3.51%)
Volume$3.54M
Capitalization77.48B
AMPH vs ZTS Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. ZTS commentary
May 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and ZTS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 16, 2025
Stock price -- (AMPH: $24.32 vs. ZTS: $160.35)
Brand notoriety: AMPH: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 106% vs. ZTS: 121%
Market capitalization -- AMPH: $2.11B vs. ZTS: $77.48B
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMPH and ZTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while ZTS’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 3 bearish.
  • ZTS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than ZTS.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а -1.34% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.68%. For the same industry, the average monthly price growth was +10.59%, and the average quarterly price growth was +26.70%.

Reported Earning Dates

AMPH is expected to report earnings on Aug 11, 2025.

ZTS is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.68% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than AMPH($2.11B). ZTS has higher P/E ratio than AMPH: ZTS (32.94) vs AMPH (16.69). ZTS YTD gains are higher at: -0.953 vs. AMPH (-34.500). ZTS has higher annual earnings (EBITDA): 3.67B vs. AMPH (240M). ZTS has more cash in the bank: 2.04B vs. AMPH (257M). AMPH has less debt than ZTS: AMPH (624M) vs ZTS (6.76B). ZTS has higher revenues than AMPH: ZTS (8.54B) vs AMPH (644M).
AMPHZTSAMPH / ZTS
Capitalization2.11B77.5B3%
EBITDA240M3.67B7%
Gain YTD-34.500-0.9533,621%
P/E Ratio16.6932.9451%
Revenue644M8.54B8%
Total Cash257M2.04B13%
Total Debt624M6.76B9%
FUNDAMENTALS RATINGS
AMPH vs ZTS: Fundamental Ratings
AMPH
ZTS
OUTLOOK RATING
1..100
1120
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
8068
SMR RATING
1..100
4119
PRICE GROWTH RATING
1..100
8759
P/E GROWTH RATING
1..100
9068
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (63) in the Pharmaceuticals Other industry is in the same range as ZTS (72) in the Pharmaceuticals Generic industry. This means that AMPH’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's Profit vs Risk Rating (68) in the Pharmaceuticals Generic industry is in the same range as AMPH (80) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to AMPH’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is in the same range as AMPH (41) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to AMPH’s over the last 12 months.

ZTS's Price Growth Rating (59) in the Pharmaceuticals Generic industry is in the same range as AMPH (87) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to AMPH’s over the last 12 months.

ZTS's P/E Growth Rating (68) in the Pharmaceuticals Generic industry is in the same range as AMPH (90) in the Pharmaceuticals Other industry. This means that ZTS’s stock grew similarly to AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHZTS
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 5 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
57%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
60%
Advances
ODDS (%)
Bullish Trend 9 days ago
72%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
53%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+4.38%
AMRX - AMPH
34%
Loosely correlated
+2.04%
ALKS - AMPH
31%
Poorly correlated
+1.93%
EOLS - AMPH
29%
Poorly correlated
+0.10%
SUPN - AMPH
27%
Poorly correlated
+2.98%
ORGO - AMPH
27%
Poorly correlated
+0.66%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
+3.51%
ELAN - ZTS
36%
Loosely correlated
+0.47%
AMRX - ZTS
35%
Loosely correlated
+2.04%
VTRS - ZTS
35%
Loosely correlated
+4.39%
AMPH - ZTS
32%
Poorly correlated
+4.38%
HLN - ZTS
32%
Poorly correlated
+2.60%
More